The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Mesoporous silica nanoparticles: Synthesis, pharmaceutical applications, biodistribution, and biosafety assessment
Abstract
Abstract Mesoporous silica nanoparticles (MSNs) are a key example of the innovation in material science to develop nanotechnology-based delivery systems. Biological and pharmaceutical applications of the MSNs garnered more attention recently due to their potential in carrying therapeutic agents. When utilized as nanocarriers, the uniquely structured MSNs are capable of acting as an effective drug, gene, protein, and antigen delivery vehicle for an assortment of therapeutic regimens to mitigate the progress of diseases, inflammatory responses, and cancer. The biocompatibility of MSN particles along with their multipurpose applications have been the subject of multiple studies in the nano/biotechnology and nanomedical communities concerning the effective and safe use of these delivery systems for diagnosis and management of various diseases. Concentrating on their drug vector applicability, this review presents an in-depth overview and discussion on the biosafety of MSNs and their evaluation in clinical trials. Additionally, other impactful issues surrounding the synthetic aspects, biological use (i.e., drug delivery, gene delivery, protein delivery and antigen delivery), uptake pathway, as well as other points of interest for MSNs will be discussed. To conclude the review, a discussion concerning emerging trends alongside the anticipated future advancements for these carries will be undertaken.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Etheridge, M. L., Campbell, S. A., Erdman, A. G., Haynes, C. L., Wolf, S. M., & McCullough, J. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.05.013 · Cited by 1,088
Gene therapy using adeno-associated virus vectors
Daya, S., & Berns, K. I. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-08 · Cited by 926
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721
Tailoring nanocarriers for intracellular protein delivery
Gu, Z., Biswas, A., Zhao, M., & Tang, Y. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00227e · Cited by 543
Biocompatibility and drug delivery systems
Kohane, D. S., & Langer, R. (2010) · Chem. Sci. · doi:10.1039/c0sc00203h · Cited by 307
Cited by
Multifunctional mesoporous silica nanoparticles for biomedical applications
Xu, B., Li, S., Shi, R., & Liu, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01654-7 · Cited by 433
Natural carbon-based quantum dots and their applications in drug delivery: A review
Nair, A., Haponiuk, J. T., Thomas, S., & Gopi, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110834 · Cited by 329
Farjadian, F., Abbaspour, S., Sadatlu, M. A. A., Mirkiani, S., Ghasemi, A., Hoseini‐Ghahfarokhi, M., Mozaffari, N., Karimi, M., & Hamblin, M. R. (2020) · ChemistrySelect · doi:10.1002/slct.202002501 · Cited by 323
Self-citationMane, P. V., Rego, R. M., Yap, P. L., Losic, D., & Kurkuri, M. D. (2024) · Progress in Materials Science · doi:10.1016/j.pmatsci.2024.101314 · Cited by 271
Elkhalifa, A. M. E., Nazar, M., Ali, S. I., Khursheed, I., Taifa, S., Ahmad Mir, M., Shah, I. H., Malik, M., Ramzan, Z., Ahad, S., et al. (2024) · Life · doi:10.3390/life14010099 · Cited by 31
Metadata
- Authors
- Farjadian, F., Roointan, A., Mohammadi-Samani, S., & Hosseini, M.
- Venue
- Chemical Engineering Journal
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 359
- Pages
- 684-705
- ISSN
- 1385-8947 (ISSN-L)
- OpenAlex
- W2900625966
- Cited by
- 234
- References
- 11
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mesoporous silica nanoparticles: Synthesis, pharmaceutical applications, biodistribution, and biosafety assessment. https://app.cochat.ai/papers/10.1016/j.cej.2018.11.156
- The paper
- Farjadian, F., Roointan, A., Mohammadi-Samani, S., & Hosseini, M. (2019). Mesoporous silica nanoparticles: Synthesis, pharmaceutical applications, biodistribution, and biosafety assessment. Chemical Engineering Journal. https://doi.org/10.1016/j.cej.2018.11.156
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.